Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

0
Player Avatar esebeus (48.41) Submitted: 12/28/2006 10:39:40 PM : Outperform Start Price: $1.73 CLRT Score: +189.73

Ask the pathologists.

Featured Broker Partners


Advertisement